The recently identified FSP1 inhibitor 3-phenyl quinazolinones, represented by icFSP1, could induce FSP1 agglutination in tumors and synergize with ferroptosis inducers to enhance the ferroptosis response, thereby inhibiting tumor growth in vivo [64]. Here, AIFM2 is linked to neoplasm.